December 22, 2017 / 9:19 PM / 9 months ago

BRIEF-Bausch + Lomb Receives FDA Approval Of Lumify

Dec 22 (Reuters) - Valeant Pharmaceuticals International Inc :

* BAUSCH + LOMB RECEIVES FDA APPROVAL OF LUMIFY™ - THE ONLY OVER-THE-COUNTER EYE DROP WITH LOW-DOSE BRIMONIDINE FOR THE TREATMENT OF EYE REDNESS

* VALEANT - EXPECT LUMIFY WILL BE AVAILABLE FOR PURCHASE IN MAJOR RETAILERS IN Q2 OF 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below